21-CHLORO-9-FLUORO-11.BETA.,17-DIHYDROXY-16.ALPHA.-((2-METHYL-2-PROPENYL)OXY)PREGNA-1,4,DIENE-3,20-DIONE
UNII K013QIU9IH
Substance Identification & Data
This profile provides standardized clinical and technical data for 21-chloro-9-fluoro-11.beta.,17-dihydroxy-16.alpha.-((2-methyl-2-propenyl)oxy)pregna-1,4,diene-3,20-dione, uniquely identified by the FDA Unique Ingredient Identifier (UNII) K013QIU9IH.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 57331-56-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C25H32ClFO5 HNVJCMRHHGMCQR-RBWIMXSLSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 21-chloro-9-fluoro-11.beta.,17-dihydroxy-16.alpha.-((2-methyl-2-propenyl)oxy)pregna-1,4,diene-3,20-dione. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.